17285-36-8 Usage
General Description
5,6-Dichloropyridazin-3(2H)-one is a chemical compound that belongs to the class of pyridazine derivatives. It is a white crystalline solid with a molecular formula of C4H2Cl2N2O. 5,6-Dichloropyridazin-3(2H)-one is commonly used in the synthesis of pharmaceuticals and agrochemicals, and it exhibits a wide range of biological activities. It has shown potential as an antimicrobial, antiparasitic, and antiviral agent in various studies. Additionally, 5,6-Dichloropyridazin-3(2H)-one has also been studied for its potential applications in material science and as a reagent in organic synthesis. Therefore, its versatile properties and wide range of potential applications make it an important compound in various scientific fields.
Check Digit Verification of cas no
The CAS Registry Mumber 17285-36-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,2,8 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 17285-36:
(7*1)+(6*7)+(5*2)+(4*8)+(3*5)+(2*3)+(1*6)=118
118 % 10 = 8
So 17285-36-8 is a valid CAS Registry Number.
InChI:InChI=1/C4H2Cl2N2O/c5-2-1-3(9)7-8-4(2)6/h1H,(H,7,9)
17285-36-8Relevant articles and documents
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
-
Page/Page column 56, (2021/06/11)
The invention relates to a compound of Formula I, pharmaceutical compositions comprising a compound of Formula I, and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I to
BROMODOMAIN INHIBITORS
-
Page/Page column 116, (2015/06/25)
The present invention provides for compounds of formula (I) wherein Rx, X, Y, Y1, L1, A1, A2, A3, A4, A5, A6, A7, and A8, have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).
Pyridinone and Pyridazinone Derivatives
-
Paragraph 0749, (2014/01/08)
The present invention provides for compounds of formula (I) wherein A1, A2, A3, A4, J, and X3 have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereo
